David F Ackerley - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David F Ackerley

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Nature Methods|February 8, 2022

NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablationAbigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.

Elife|June 29, 2021

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosaLiyun Zhang, Conan Chen, Jie Fu, et al.

Nature Immunology|July 20, 2023

mRNA vaccine against malaria tailored for liver-resident memory T cellsMitch Ganley, Lauren E Holz, Jordan J Minnell, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Nature Methods|February 8, 2022

NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablationAbigail V Sharrock, Timothy S Mulligan, Kelsi R Hall, et al.

Elife|June 29, 2021

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosaLiyun Zhang, Conan Chen, Jie Fu, et al.

Nature Immunology|July 20, 2023

mRNA vaccine against malaria tailored for liver-resident memory T cellsMitch Ganley, Lauren E Holz, Jordan J Minnell, et al.

Pageof 9